Ustekinumab (Pyzchiva)
Pyzchiva (Ustekinumab) is a biologic medicine that suppresses the immune system in order to treat psoriatic arthritis and psoriasis.
Pyzchiva works by blocking two signalling proteins called cytokines named interleukin-12 (IL-12) and interleukin-23 (IL-23). These cytokines regulate the body’s immune system and are related to its inflammatory response.
Biosimilar
Pyzchiva is a type of medicine that is called a biosimilar. A biosimilar is a type of biologic medication that is designed to be identical to an existing biologic medication, but is created using a different process.
Pyzchiva is a biosimilar of Stelara. Both medications are known by the same generic name: ustekinumab. Biosimilars are often cheaper than the original medication.
Taking Pyzchiva
Pyzchiva comes in a pre-filled syringe for subcutaneous (under the skin) injection that can be administered at home.
Although some patients who take Pyzchiva can feel better quite quickly, in others it can take a little longer. It is important to keep taking this medicine as prescribed by a doctor.
Patients starting Pyzchiva will receive an injection on week 0, week 4, and then every 12 weeks after that.
The normal dose is either 45 or 90 mg and is based on body weight.
Watch our video to learn how inject Pyzchiva at home:
Learn how to inject subcutaneous injections with a pre filled syringeSubcutaneous injections are easy to do compared to other types of injections. A small needle pokes just under the skin to deliver medicine into the “fatty tissue” below.
Important Tests and Risks
Pyzchiva can make it a bit harder for people to fight off infections.
Patients taking this medicine should call their doctor they have a fever, think they have an infection, or have been prescribed antibiotics to treat an infection.
Patients should coordinate with their doctor to stop treatment before any surgery. It can be re-started once things have healed and there’s no sign of infection.
Patients should discuss all vaccinations with their doctor because some (live vaccines) are not advisable to get while taking Pyzchiva.
It is important to get a TB (tuberculosis) skin test and a chest x-ray before starting Pyzchiva.
It is important for patients who are taking Pyzchiva to get occasional blood tests as requested by their doctor to keep an eye on blood counts and monitor their arthritis.
Science
Pyzchiva works by blocking two signalling proteins, or cytokines, called interleukin-12 (IL-12) and interleukin-23 (IL-23).
IL-12 and IL-23 regulate the immune system and are related to the body’s inflammatory response.
Pyzchiva is itself a type of protein known as a monoclonal antibody. It binds to both IL-12 and IL-23, and in doing so, prevents them from binding to their receptors.
Immune system cells like T-cells, a type of white blood cell, rely on signals like IL-12 and IL-23 to become activated or “switched on”.
When IL-12 and IL-23 are tied up by Pyzchiva, the messages that would normally fire up T-cells don’t get through as often, and the overall effect is suppression of the immune system.
While suppressing the immune can make it slightly harder for patients to fight off infections, it also helps to stabilize an overactive immune system and treat the symptoms of arthritis and psoriasis.
Safety
The most common side effects of Pyzchiva are upper respiratory tract infections (nasopharyngitis) and headache.
Other possible side effects include:
- Injection site reaction – Pyzchiva can rarely cause a reaction (redness, pain, & itching) at the injection site. Patients should tell their doctor if these are severe.
- Rare brain problems – Some patients have very rarely developed a rare brain problem called Reversible Posterior Leukoencephalopathy Syndrome while taking Pyzchiva. This is very rare and potentially reversible. Pyzchiva should be stopped if this occurs.
- Cancer – Ustekinumab has very rarely been associated with developing cancer. Patients should tell their doctor if they have had cancer in the past or have a family history of cancer.
People that should NOT take Pyzchiva include:
- Those with a fever or possible infection
- Pregnant or breastfeeding women
- Anyone who has had an allergic reaction to Pyzchiva
- People who have had a rare brain problem called Reversible Posterior Leukoencephalopathy Syndrome
- Possibly patients with a history of certain types of cancers
Patients who are about to have surgery should discuss stopping Pyzchiva with their doctor. The medication can be restarted once things have healed and there are no signs of infection.
People taking Pyzchiva should call a doctor if they feel sick and want to stop, or if they are concerned about any side effects.
Other reasons for people taking Pyzchiva to call a doctor include:
- Fever or possible infection
- Upcoming surgery
- Becoming pregnant or planning on pregnancy
- Planning any vaccinations
- Headache, confusion, seizures, or vision trouble
Anyone who becomes pregnant while taking Pyzchiva should notify their doctor.
Pregnancy and medicationsResources
DIN
- 02550539
- 02550547